A study to compare the pharmacokinetics of budesonide and albuterol delivered by PT027 compared with PT007 and PT008 administered separately.

Trial Identifier: D6930C00003
Sponsor: AstraZeneca
NCTID:: NCT03772223
Start Date: January 2019
Primary Completion Date: May 2019
Study Completion Date: May 2019
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United Kingdom London, United Kingdom, HA1 3UJ